MOLN vs GILD: Which Stock is Better?

Side-by-side comparison of Molecular Partners AG ADR and Gilead Sciences Inc in 2026

Comparison Updated:

MOLN

Molecular Partners AG ADR

$4.05

GILD

Gilead Sciences Inc

$124.14

Key Metrics Comparison

MetricMOLNGILDWinner
Market Cap$151.47M$154.99BGILD
P/E RatioN/A19.34GILD
EPS (TTM)$N/A$6.46GILD
Revenue Growth-1.0%0.0%GILD
Gross Margin0.0%78.7%GILD

Analyze MOLN

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MOLN or GILD a better investment?

Comparing MOLN and GILD: Molecular Partners AG ADR has a market cap of $151.47M while Gilead Sciences Inc has $154.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MOLN and GILD?

MOLN (Molecular Partners AG ADR) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MOLN or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: MOLN or GILD?

GILD has higher revenue growth at 0.0% vs -1.0% for MOLN.

Which company is more profitable: MOLN or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to 0.0% for MOLN.

Which is the larger company: MOLN or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $154.99B compared to $151.47M for MOLN.

Should I buy MOLN or GILD in 2026?

Both MOLN and GILD have investment merit. MOLN trades at $4.05 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MOLN and GILD stock?

Key differences: Market Cap ($151.47M vs $154.99B), P/E Ratio (N/A vs 19.3x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (0.0% vs 78.7%).

Popular Stock Comparisons